Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 2,179 shares at $92.80 ($196K) on 2014-05-01, disclosed to the SEC on 2014-05-02.
Scheduled sale ($196k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.50 | 300 | $26K | 13.2% |
| 2 | $87.93 | 600 | $53K | 26.9% |
| 3 | $91.55 | 1,100 | $101K | 51.4% |
| 4 | $92.80 | 179 | $17K | 8.5% |
| Total | $89.96 avg | 2,179 | $196K | 100% |
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |